Ranaz has elected a new Chairman of the board

    




 MONTREAL, Sept. 24, 2012 /CNW Telbec/ - Ranaz Corporation ("Ranaz")  , a company specializing in the manufacturing and marketing  of protein and dietary supplements, reports the nomination of Mr. André  Brosseau as Chairman of the board. 

 Mr. Brosseau is CEO and COO of Avenue Capital Partners Inc., an exempt  market dealer founded in 2010 with offices in Montreal and New York. He  is also a Director of Midas Medici Inc., a holding company specializing  in acquiring and merging IT related companies with operations in New  York, North Carolina, Europe and Brazil. He's on the Board of CIMCORP,  wholly owned by Midas Medici, an IT company based in Sao Paulo Brazil.  Mr. Brosseau is Chairman of Vantex Resources Ltd, a public mining  company. He also serves as the Co-Chair of The Company Theatre, a  not-for-profit organization located in Toronto and member of the  steering committee of Notman House. Mr. Brosseau holds a Bachelor's  Degree (BA) in Science (Political and Economics) and a Master's Degree  in Science (Political Science) from the Université de Montréal. 

 Mr. Brosseau was President of Blackmont Capital in Toronto until June  2009 and Chairman Quebec Capital Markets until May 2010. For 12 years  Mr. Brosseau was with CIBC in different capacities mostly based in  Toronto, most recently as Managing Director, Head of Cash Equities and  Co-Head of Global Cash Equities at CIBC World Markets where he was  involved in some of the most important capital market transactions in  Canada. 

 "We are very excited that André Brosseau has chosen to join Ranaz. His  expertise in investment banking will be a valuable asset for Ranaz  shareholders," said Mr. Bourassa-Marineau, CEO of Ranaz. 

 About Ranaz Corporation 

 Ranaz is a corporation specializing in the manufacture and sale of  protein and dietary supplements. Its mission is to design, develop and  market nutritional, protein and dietary supplements under its own  corporate brands and concepts, such as Protidiet and ProtiLife, as well  as under private labels. 

 Full information, including the management discussion and analysis and  the financial statements thereto, is available on SEDAR, at www.sedar.com 

 Neither the TSX Venture Exchange nor its Regulation Services Provider  (as that term is defined in the policies of the TSX Venture Exchange)  accepts responsibility for the accuracy of this release. 

Ranaz Corporation


CONTACT:  Ranaz CorporationJean Bourassa-MarineauPresident and CEO(450) 491-7106, local 217 


    

Copyright